These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 1727273
1. Contrast-enhanced MR imaging of the liver. Saini S. Radiology; 1992 Jan; 182(1):12-4. PubMed ID: 1727273 [No Abstract] [Full Text] [Related]
2. [Manganese-DPDP in the MR tomography of malignant liver tumors. The initial results with a new hepatobiliary contrast agent]. Steudel A, Layer G, Kraheck H, Hartlapp J, Reiser M. Rofo; 1992 May; 156(5):460-4. PubMed ID: 1596550 [Abstract] [Full Text] [Related]
3. Breast carcinoma metastases to the liver simulating cirrhosis. Burkill GJ, King LJ, Scurr E, Healy JC. Radiology; 2002 Dec; 225(3):917; author reply 917-8. PubMed ID: 12461279 [No Abstract] [Full Text] [Related]
5. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging. Burke C, Alexander Grant L, Goh V, Griffin N. Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317 [Abstract] [Full Text] [Related]
6. [Status and development of new clinical contrast media for MR diagnosis of liver diseases]. Rummeny EJ, Peters PE. Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982 [Abstract] [Full Text] [Related]
16. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI. Rockall AG, Planche K, Power N, Nowosinska E, Monson JP, Grossman AB, Reznek RH. Neuroendocrinology; 2009 Mar; 89(3):288-95. PubMed ID: 19023191 [Abstract] [Full Text] [Related]
17. Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients. Rummeny E, Ehrenheim C, Gehl HB, Hamm B, Laniado M, Lodemann KP, Schmiedel E, Steudel A, Vogl TG. Invest Radiol; 1991 Nov; 26 Suppl 1():S142-5; discussion S150-5. PubMed ID: 1808111 [No Abstract] [Full Text] [Related]